Gemoscan Canada, Inc. Announces Director and Chief Executive Officer Resignations
Toronto, Ontario--(Newsfile Corp. - July 21, 2020) - Gemoscan Canada, Inc. ("Gemoscan" or the "Company"), announces the resignations of Brian Kalish, Scott Wilson and James Jones. Mr. Kalish tendered his resignation as Chief Executive Officer and Director effective October 21, 2015 and January 8, 2016, respectively. Mr. Wilson and Mr. Jones tendered their resignation as Directors effective January 8, 2016.To view the source version of this press release, please visit...
2020-07-21 3:10 PM EDT
IIROC Trade Halt - Gemoscan Canada, Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2016) - The following issues have been halted by IIROC: Company:
2016-01-11 8:25 AM EST
Gemoscan Canada, Inc. Announces Director Resignation
Toronto, Ontario--(Newsfile Corp. - March 4, 2015) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), announces the resignation of Elisa Swern as a director of Gemoscan. Ms. Swern tendered her resignation effective February 28, 2015. The Board of Directors wish Ms. Swern all the best in her future endeavors.About Gemoscan Canada, Inc.Gemoscan is an industry leader in food intolerance management and maintains a first-to-market position with Canada wide distribution...
2015-03-04 12:03 PM EST
Gemoscan Canada, Inc. Announces Closing of Convertible Debenture Financing
Toronto, Ontario--(Newsfile Corp. - February 3, 2015) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) (“Gemoscan” or the “Company”), wishes to announce that, subject to TSX Venture Exchange (“TSXV”) final approval, it has completed closing a convertible debenture financing with total proceeds of $100,000. The debentures shall mature two (2) years from the date of issuance and bear interest at the rate of 9% per annum. The debentures will be secured. The debentures will be convertible into...
2015-02-03 7:20 AM EST
Gemoscan Canada, Inc. Announces Shares for Debt Settlement
Toronto, Ontario--(Newsfile Corp. - January 28, 2015) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), further to Gemoscan's press release of January 19, 2015, it wishes to announce that its proposal to settle a shares-for-debt agreement totaling $15,000 (the "Debt"), with a non-arm's-length party has been accepted by the TSX Venture Exchange. The Debt has been settled through the issuance of 300,000 Class A Shares (the "Shares") of the Corporation at a deemed...
2015-01-28 5:05 PM EST
Gemoscan Canada, Inc. Announces Option Grants, Shares for Debt Settlement & Shares for Service Settlement
Toronto, Ontario--(Newsfile Corp. - January 19, 2015) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), announces that, subject to regulatory approval, its Board of Directors has approved, effective January 16, 2015, the grant of an aggregate of 690,000 stock options (the "Options") to directors, officers and employees of the Corporation. The Options are exercisable into Class A Shares of Gemoscan at an exercise price of $0.05 per share. The Options all vest...
2015-01-19 10:51 AM EST
Gemoscan Canada, Inc. Forms Corporate Development Alliance with A.C. Simmonds and Sons
Toronto, Ontario--(Newsfile Corp. - January 15, 2015) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), is pleased to announce that it has formed a strategic alliance with A.C. Simmonds and Sons (the "Alliance"). The Alliance will focus on corporate and business development initiatives focused around Gemoscan's previously stated goals of leveraging its patented intellectual property and proprietary processes to become one of the leading integrated platforms in the...
2015-01-15 5:05 PM EST
Demand Drives Gemoscan Canada, Inc. to Establish U.S Subsidiary and Investment by Value Added Reseller
Toronto, Ontario--(Newsfile Corp. - January 13, 2015) - Pursuant to its news release of August 07, 2014, Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) (“Gemoscan” or the “Company”), is pleased to announce that it has established a wholly owned subsidiary, Hemocode USA, Inc., (“HUI”) through which to sell and market its HemocodeTM and other leading food sensitivity management programs. HUI has been set up under the laws of the state of Delaware. In addition, Gemoscan is pleased to announce that...
2015-01-13 5:05 PM EST
IIROC Trade Resumption - Gemoscan Canada, Inc.
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2014) - Trading resumes in: Company: Gemoscan Canada, Inc.
2014-12-18 4:11 PM EST
Gemoscan Canada, Inc. Provides Corporate Development Update
Toronto, Ontario--(Newsfile Corp. - December 18, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), announced today that while the Company has attempted to finalize the previously announced proposed acquisition of all of the issued and outstanding common shares of 2275518 Ontario Inc. and related companies, jointly known and presented as Abira Healthcare ("Abira"); Abira and its principals have, despite repeated requests by the Company, to date, not yet...
2014-12-18 9:20 AM EST
Gemoscan Canada, Inc. Announces Improved Sales Results for Three and Six Months Ended September 30, 2014 and Provides Further Corporate Development Update
Toronto, Ontario--(Newsfile Corp. - November 27, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) (“Gemoscan” or the “Company”), today reported operational and financial results for the second quarter ended September 30, 2014. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Accounting Standards 34 ‘Interim Financial Reporting’ using accounting policies consistent with International Financial Reporting...
2014-11-27 5:10 PM EST
Gemoscan Canada, Inc. Announces Improved Sales Results for Q1 2015 and Provides Additional Corporate Development Update
Toronto, Ontario--(Newsfile Corp. - August 29, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), today reported operational and financial results for the first quarter ended June 30, 2014. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Accounting Standards 34 'Interim Financial Reporting' using account policies consistent with International Financial Reporting Standards....
2014-08-29 5:01 PM EDT
The Hemocode(TM) System to be Available in the United States - Gemoscan Canada, Inc. Partners with U.S. Lab to Provide its Food Sensitivity Management Programs
Toronto, Ontario--(Newsfile Corp. - August 7, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), is pleased to announce that the Hemocode™ System and its other food sensitivity management programs are expected to be available in the United States in the third or fourth quarter of this 2014. Working with its exclusive laboratory partner, American Metabolic Testing Laboratories, Inc., ("AMTL"), Gemoscan has completed work on the laboratory protocols necessary to...
2014-08-07 11:15 AM EDT
Gemoscan Canada, Inc. Announces Improved Annual Financial Results and Provides Additional Corporate Development Update
Toronto, Ontario--(Newsfile Corp. - July 31, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), today reported operational and financial results for the fourth quarter and 12 months ended March 31, 2014. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Financial Reporting Standards (IFRS). Improved results were generated by the Company's regular focus on the emerging retail...
2014-07-31 12:39 PM EDT
Gemoscan Canada, Inc. Provides Corporate Development Update
Toronto, Ontario--(Newsfile Corp. - June 30, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Corporation") is providing this release as an update to its recently announced corporate development initiatives. Pursuant to the Company's news release of May 08, 2014, due diligence continues to progress on the Company's proposed two stage transaction resulting in the intended acquisition of a 100% interest in 7 paramedical clinics currently owned by Novo Healthnet, in...
2014-06-30 12:09 PM EDT
Gemoscan Canada, Inc. Set to Acquire Abira Healthcare
Toronto, Ontario--(Newsfile Corp. - May 28, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Corporation") is pleased to announce that it has entered into a letter of intent dated May 26, 2014 to acquire all of the issued and outstanding common shares (the "Target Shares") of 2275518 Ontario Inc. operating as Abira Healthcare ("Abira"). The purchase price of the Target Shares will be determined by using a multiple of five times Abira's net cash flow as determined...
2014-05-28 9:49 AM EDT
IIROC Trade Halt - Gemoscan Canada, Inc.
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2014) - The following issues have been halted by IIROC: Company:
2014-05-28 8:07 AM EDT
Gemoscan Canada, Inc. Announces the Proposed Acquisition of the Operations of 7 Novo Healthnet Clinics
Toronto, Ontario--(Newsfile Corp. - May 8, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Corporation") wishes to announce that it has entered into a letter of intent to undertake a two stage transaction resulting in the Corporation acquiring from Novo Healthnet ("Novo") a 100% interest in 7 paramedical clinics currently owned by Novo ("Novo Businesses") in Southern and Southwestern Ontario (the "Acquisition"). Pursuant to the first phase of the acquisition, the...
2014-05-08 4:00 PM EDT
Gemoscan Extends Maturity Date of Secured Loan and Debenture
Toronto, Ontario--(Newsfile Corp. - April 1, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company") is pleased to announce that the TSX Venture Exchange ("TSXV") has consented to its application to extend the maturity date of a secured loan and debenture. On April 8, 2013, Gemoscan announced it had entered into a secured loan agreement and debenture with a non-arm's length party (the "Lender"). The Lender has provided the Corporation a $350,000 loan (the...
2014-04-01 10:40 AM EDT
Gemoscan Announces Substantially Improved Financial Results for Q3 2014
Toronto, Ontario--(Newsfile Corp. - February 27, 2014) - Gemoscan Canada, Inc. (TSXV: GES) (MUN: 1GE) ("Gemoscan" or the "Company"), a leading owner and marketer of food sensitivity and dietary management solutions, today reported operational and financial results for the third quarter and 9 months ended December 31, 2013. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Financial Reporting Standards (IFRS)....
2014-02-27 8:57 PM EST